Astria Therapeutics (ATXS) Change in Cash: 2017-2019
Historic Change in Cash for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2019 value amounting to -$7.5 million.
- Astria Therapeutics' Change in Cash fell 63.73% to -$7.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$5.0 million, marking a year-over-year decrease of 368.00%. This contributed to the annual value of -$115.9 million for FY2024, which is 174.75% down from last year.
- As of Q4 2019, Astria Therapeutics' Change in Cash stood at -$7.5 million, which was down 192.05% from $8.2 million recorded in Q3 2019.
- In the past 5 years, Astria Therapeutics' Change in Cash ranged from a high of $32.9 million in Q2 2018 and a low of -$30.1 million during Q3 2018.
- Moreover, its 3-year median value for Change in Cash was -$3.0 million (2017), whereas its average is -$1.1 million.
- Per our database at Business Quant, Astria Therapeutics' Change in Cash surged by 1,456.18% in 2018 and then crashed by 650.98% in 2019.
- Over the past 3 years, Astria Therapeutics' Change in Cash (Quarterly) stood at -$5.3 million in 2017, then increased by 14.26% to -$4.6 million in 2018, then slumped by 63.73% to -$7.5 million in 2019.
- Its Change in Cash stands at -$7.5 million for Q4 2019, versus $8.2 million for Q3 2019 and -$2.0 million for Q2 2019.